Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Johnson & Johnson $JNJ Shares Sold by Tweedy Browne Co LLC
Warren Buffett and Berkshire Hathaway Own 2 Dividend Kings That Will Never Be Sold
Sumitomo Mitsui DS Asset Management Company Ltd Buys 5,947 Shares of Johnson & Johnson $JNJ - Zolmax
Nordwand Advisors LLC Has $566,000 Stake in Johnson & Johnson $JNJ
Providence First Trust Co Invests $1.18 Million in Johnson & Johnson $JNJ - Stock Observer
What is Erste Group Bank's Estimate for JNJ FY2027 Earnings? - Daily Political
Sumitomo Mitsui DS Asset Management Company Ltd Grows Position in Johnson & Johnson $JNJ - Daily Political
IP in the deal room: The risks that bite before, during and after closing
Bi-Specific MAbS Market Research Report 2026: $21.83 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark
Johnson & Johnson $JNJ Shares Acquired by Truist Financial Corp
Peregrine Asset Advisers Inc. Boosts Stake in Johnson & Johnson $JNJ
Johnson And Johnson Gains STELARA Approval As Shares Trade Below Targets
QRG Capital Management Inc. Has $80.46 Million Stock Position in Johnson & Johnson $JNJ - Stock Observer
Peregrine Asset Advisers Inc. Grows Holdings in Johnson & Johnson $JNJ - Daily Political
Principal Financial Group Inc. Buys 28,370 Shares of Johnson & Johnson $JNJ - Daily Political
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? - AOL
6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash
These 3 Dividend Stocks Have Raised Their Payouts for a Combined 187 Years. Here's Why That Matters To Passive Income Lovers - 24/7 Wall St.
Reynders McVeigh Capital Management LLC Sells 2,402 Shares of Johnson & Johnson $JNJ - Zolmax
Strs Ohio Has $174.11 Million Stock Position in Johnson & Johnson $JNJ
Ottava Robotic Surgery Milestone Adds New Dimension To Johnson And Johnson
Benjamin Edwards Inc. Acquires 10,177 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Sold by CENTRAL TRUST Co - Stock Observer
RIA Advisory Group LLC Acquires 3,806 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson $JNJ Shares Sold by Intact Investment Management Inc. - Daily Political
Reynders McVeigh Capital Management LLC Has $15.77 Million Holdings in Johnson & Johnson $JNJ - Daily Political
PKO Investment Management Joint Stock Co Sells 17,151 Shares of Johnson & Johnson $JNJ - Daily Political
As American Water Works Hikes Its Dividend, Consider Buying AWK Stock in May
27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income
Healthcare Stocks To Follow Today - May 5th - Stock Observer
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease | Morningstar
Johnson & Johnson $JNJ Shares Sold by Kornitzer Capital Management Inc. KS
Johnson & Johnson $JNJ Stock Position Decreased by Horizon Investments LLC
Artemis Investment Management LLP Has $11.62 Million Stock Position in Johnson & Johnson $JNJ
Madrigal expands MASH pipeline in potential $1B Arrowhead deal | BioWorld
Assessing Johnson & Johnson (JNJ) Valuation After Fresh FDA Wins In Rare Disease And Neuropsychiatry - Simply Wall St News
Artemis Investment Management LLP Boosts Stock Holdings in Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson (NYSE:JNJ) Shares Down 1.3% - Here's Why - Zolmax
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment | Markets Insider
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
Are Wall Street Analysts Bullish on Johnson & Johnson Stock?
A $2 Million Portfolio Still Has a Safety Trap Most Investors Over 60 Miss
Johnson & Johnson's Caplyta Shows Promising Results in Depression Treatment
J & J's Caplyta Shows Better Efficacy Among Adjunctive MDD Treatments In Network Meta-Analysis
Johnson & Johnson's (JNJ) Accelerating Growth Justifies the Higher Multiple
Johnson & Johnson $JNJ Stake Lowered by Oppenheimer Asset Management Inc. - Zolmax
Top Healthcare Stocks Worth Watching - May 4th - Daily Political
Johnson & Johnson $JNJ Shares Sold by Oppenheimer & Co. Inc.
Johnson & Johnson $JNJ Stock Holdings Lessened by Oppenheimer Asset Management Inc.
Johnson & Johnson $JNJ Shares Sold by New York State Teachers Retirement System
The Best Dividend Stocks to Buy and Hold Forever
Johnson & Johnson $JNJ Position Boosted by Cullinan Associates Inc. - Zolmax
Johnson & Johnson $JNJ Shares Bought by Citizens Financial Group Inc. RI - Zolmax
Danske Bank A S Boosts Position in Johnson & Johnson $JNJ
Cullinan Associates Inc. Purchases 7,051 Shares of Johnson & Johnson $JNJ
Fifth Third Bancorp Acquires 28,353 Shares of Johnson & Johnson $JNJ
Verity Asset Management Inc. Cuts Position in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson $JNJ Stock Holdings Lifted by Keybank National Association OH
Canandaigua National Bank & Trust Co. Trims Stock Holdings in Johnson & Johnson $JNJ
Pipeline Wins And Dividend Hike Might Change The Case For Investing In Johnson & Johnson (JNJ) - Simply Wall St News
Johnson & Johnson $JNJ Position Trimmed by United Community Bank
Johnson & Johnson $JNJ is Vest Financial LLC's 10th Largest Position
5,644 Shares in Johnson & Johnson $JNJ Purchased by Wealthstar Advisors LLC
Flossbach Von Storch SE Sells 1,589,548 Shares of Johnson & Johnson $JNJ
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?
Wealthfront Advisers LLC Buys 13,455 Shares of Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Given Average Rating of "Moderate Buy" by Analysts
Flossbach Von Storch SE Has $290.89 Million Stock Position in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1% - Should You Sell?
Healthcare Stocks To Watch Today - April 28th - Zolmax
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
Managed Asset Portfolios LLC Decreases Position in Johnson & Johnson $JNJ - Zolmax
Johnson & Johnson $JNJ Shares Sold by State of Michigan Retirement System - Zolmax
J&J axes $5B CAR-T dream months after touting efficacy edge
Johnson & Johnson $JNJ Shares Bought by Pictet Asset Management Holding SA
FARMERS & MERCHANTS TRUST Co OF LONG BEACH Has $5.44 Million Position in Johnson & Johnson $JNJ - Zolmax
Pictet Asset Management Holding SA Purchases 51,447 Shares of Johnson & Johnson $JNJ - Stock Observer
D.A. Davidson & CO. Sells 9,309 Shares of Johnson & Johnson $JNJ
Nichols & Pratt Advisers LLP MA Trims Position in Johnson & Johnson $JNJ - Daily Political
Top Medical Stocks To Consider - April 27th - Stock Observer
Pinion Investment Advisors LLC Buys Shares of 2,369 Johnson & Johnson $JNJ - Zolmax
Impax Asset Management Group plc Has $22.43 Million Stock Position in Johnson & Johnson $JNJ - Zolmax
Best Healthcare Stocks To Follow Today - April 30th
Johnson Controls Stock: Analyst Estimates & Ratings
ST Germain D J Co. Inc. Sells 3,304 Shares of Johnson & Johnson $JNJ - Daily Political
Vanguard Group Inc. Has $49.74 Billion Stock Holdings in Johnson & Johnson $JNJ - Stock Observer
$4+ Billion OTC Dry Eye Drops Market Analysis Report 2026: Pfizer, Johnson & Johnson Services, and Novartis International Dominate
Johnson & Johnson (JNJ) Highlights Sustained Efficacy in Vivacity-MG3 Trial
Johnson & Johnson $JNJ Shares Sold by AEGON ASSET MANAGEMENT UK Plc
Johnson And Johnson Trial Puts Boston Scientific Growth Story Under Scrutiny
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
